Concepedia

Influence of variants of Fcγ receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor α therapy in rheumatoid arthritis

Juan D. Cañete, B. Suárez, M.V. Hernández, Raimón Sanmartí, Raquel Celis, Concepción Moll, José Pinto, Francisco J. Blanco, Francisco Lozano

Annals of the Rheumatic Diseases · 2008 · 104 citations · 14 references

DOI

Concepts

References

14

Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

Peter E. Lipsky, Désirée van der Heijde, E. William St. Clair et al. · New England Journal of Medicine · 2000 · 3K citations · Full text

, , +14

A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate

Michael E. Weinblatt, Joel M. Kremer, Arthur D. Bankhurst et al. · New England Journal of Medicine · 1999 · 2.1K citations · Full text

, , +17

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

Michael E. Weinblatt, Edward Keystone, Daniel E. Furst et al. · Arthritis & Rheumatism · 2003 · 1.8K citations

, , +15

INFLIXIMAB AND METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS

P Eter E. L Ipsky, E. W Illiam, D Aniel E. F Urst et al. · 2000 · 1.2K citations

, , +14

FcγRIIIa-158V/F Polymorphism Influences the Binding of IgG by Natural Killer Cell FcγRIIIa, Independently of the FcγRIIIa-48L/R/H Phenotype

Harry R. Koene, Marion Kleijer, Johan Algra et al. · Blood · 1997 · 782 citations · Full text

, , +12